Current Challenges in Infectious Diseases Post COVID-19 Pandemic
A special issue of Microorganisms (ISSN 2076-2607). This special issue belongs to the section "Public Health Microbiology".
Deadline for manuscript submissions: 31 January 2025 | Viewed by 144
Special Issue Editor
Interests: viral infections; emerging pathogens; infection control; antimicrobial resistance; antimicrobial stewardship; public health; medical education
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
After the SARS-CoV-2 pandemic, our diagnostic capabilities have flourished, particularly against viral pathogens. This diagnostic explosion is neither easily implemented nor affordable across countries. What is the new diagnostic holy grail: omics, large panels of biomarkers, or strategies that could support precision medicine (and which ones)? How can less developed countries follow the stream? From the therapeutic viewpoint, we witnessed hundreds of clinical trials leading to the approval of only a handful of drugs against COVID-19. Will it be the mainstay thereafter? Will this clinical trial trend with adaptive design result in new products against multidrug-resistant pathogens that are urgently needed? Authors are welcome to describe their current therapeutic challenges with difficult-to-treat pathogens. Challenges could stem from the pathogen, the host, the local infrastructures, or financial obstacles. In some countries, there has been a rebound of all previous problems post pandemic. What about infection-control practices after COVID-19? Are there paradigms of hospitals that have reverted to successful infection control strategies after the jeopardy caused by the pandemic? Antibiotics are still over-prescribed in viral infections in hospitals and in the community. What is the impact of this practice currently and what will it be in the years to come? What would be the role of artificial intelligence in all three aspects described above?
Dr. Garyphallia Poulakou
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Microorganisms is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- SARS-CoV-2
- COVID-19
- pandemic
- viral pathogens
- Antibiotics
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
